Poolbeg Pharma PLC (POLBF PINK) stock market data APIs
$0.0914
0.02(21.9%)
as of June 12, 2026
Try our APIs with
free plan!
Poolbeg Pharma PLC Financial Data Overview
Price chart is built with
Anychart
Poolbeg Pharma PLC, a clinical-stage biopharmaceutical company, engages in developing immunotherapy for cancer in the United Kingdom. The company develops POLB 001, which is completed phase 1 clinical study for cancer immunotherapy-induced cytokine release syndrome; and phase 2 for the treatment of influenza. It also developing oral encapsulated GLP-1R agonist for obesity and diabetes treatment; and AI program, a novel drug discovery therapies for the treatment of influenza and respiratory syncytial viruses. Poolbeg Pharma plc was incorporated in 2021 and is headquartered in London, the United Kingdom.
Prev. Close
0.0914
Open
0.1084
High
0.1094
Low
0.0909
52 wk Range
0.042-0.196
Market Cap
64 799 K
Shares Outstanding
705 M
Beta
1.821
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Poolbeg Pharma PLC data using free add-ons & libraries
Get Poolbeg Pharma PLC Fundamental Data
Poolbeg Pharma PLC Fundamental data includes:
- Net Revenue:
- EBITDA: -6 272 000
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-05-18
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Poolbeg Pharma PLC News
New
Poolbeg Pharma on patent grant and plans - ICYMI
Poolbeg Pharma on patent grant and plans - ICYMI Proactive uses images sourced from Shutterstock Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF) earlier this week announced that it had secured it...
Here's Why We're Not At All Concerned With Poolbeg Pharma's (LON:POLB) Cash Burn Situation
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, although software-as-a-service business Salesforce.com l...
Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing
Virtual Investor Conferences NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from ...
UPDATE - Life Sciences Investor Forum: Company Executives Present Live June 23rd
Virtual Investor Conferences Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com NEW YORK, June 21, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the...
Get Poolbeg Pharma PLC fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
